Skip to main content
Canadian Medical Association Journal logoLink to Canadian Medical Association Journal
. 1976 Nov 20;115(10):1016–1019.

Possible mechanisms of normal amylase activity in hyperlipemic pancreatitis.

S Mishkin, J Bates, J O'Hashi, P Schneider, A D Sniderman, R O Wolf
PMCID: PMC1878885  PMID: 206333

Abstract

Lipemic serum from three patients with acute pancreatitis and type IV hyperlipemia was fractionated into very-low-density lipoproteins and clear serum. Amylase activity (determined by the Phadebas method) in the component fractions did not exceed that in the original lipemic serum. Addition of these fractions or VLDL and chylomicrons from asymptomatic patients with hyperlipemia to nonlipemic serum from patients with "routine acute pancreatitis" did not inhibit amylase activity or alter the electrophoretic mobility of amylase isoenzymes. Therefore the normal amylase activity often observed in hyperlipemic pancreatitis does not result from an inhibition of amylase activity by serum lipoproteins.

Full text

PDF
1016

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cameron J. L., Capuzzi D. M., Zuidema G. D., Margolis S. Acute pancreatitis with hyperlipemia: the incidence of lipid abnormalities in acute pancreatitis. Ann Surg. 1973 Apr;177(4):483–489. doi: 10.1097/00000658-197304000-00017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Cameron J. L., Crisler C., Margolis S., DeMeester T. R., Zuidema G. D. Acute pancreatitis with hyperlipemia. Surgery. 1971 Jul;70(1):53–61. [PubMed] [Google Scholar]
  3. Ceska M., Birath K., Brown B. A new and rapid method for the clinical determination of alpha-amylase activities in human serum and urine. Optimal conditions. Clin Chim Acta. 1969 Dec;26(3):437–444. doi: 10.1016/0009-8981(69)90071-0. [DOI] [PubMed] [Google Scholar]
  4. Fallat R. W., Vester J. W., Glueck C. J. Suppression of amylase activity by hypertriglyceridemia. JAMA. 1973 Sep 10;225(11):1331–1334. [PubMed] [Google Scholar]
  5. Fredrickson D. S., Levy R. I., Lindgren F. T. A comparison of heritable abnormal lipoprotein patterns as defined by two different techniques. J Clin Invest. 1969 Nov;47(11):2446–2457. doi: 10.1172/JCI105927. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. HAVEL R. J., EDER H. A., BRAGDON J. H. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest. 1955 Sep;34(9):1345–1353. doi: 10.1172/JCI103182. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. LEVINE J. B., ZAK B. AUTOMATED DETERMINATION OF SERUM TOTAL CHOLESTEROL. Clin Chim Acta. 1964 Oct;10:381–384. doi: 10.1016/0009-8981(64)90073-7. [DOI] [PubMed] [Google Scholar]
  8. Mishkin S., O'Hashi J., Schneider P. Letter: Amylase activity in hyperlipemic pancreatitis. JAMA. 1974 Apr 29;228(5):568–569. doi: 10.1001/jama.1974.03230300016015. [DOI] [PubMed] [Google Scholar]
  9. Warshaw A. L., Bellini C. A., Lesser P. B. Inhibition of serum and urine amylase activity in pancreatitis with hyperlipemia. Ann Surg. 1975 Jul;182(1):72–75. doi: 10.1097/00000658-197507000-00014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Wolf R. O., Taussig L. M. Human amniotic fluid isoamylases. Functional development of fetal pancreas and salivary glands. Obstet Gynecol. 1973 Mar;41(3):337–342. [PubMed] [Google Scholar]

Articles from Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES